Items where Author is "Zamani, P."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 29.

Article

Zamani, P. and Navashenaq, J. G. and Teymouri, M. and Karimi, M. and Mashreghi, M. and Jaafari, M. R. (2020) Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy. Life Sciences, 252.

Zamani, P. and Navashenaq, J. G. and Teymouri, M. and Karimi, M. and Mashreghi, M. and Jaafari, M. R. (2020) Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy. Life Sciences, 252.

Zamani, P. and Navashenaq, J. G. and Teymouri, M. and Karimi, M. and Mashreghi, M. and Jaafari, M. R. (2020) Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy. Life Sciences, 252.

Navashenaq, J. G. and Zamani, P. and Nikpoor, A. R. and Tavakkol-Afshari, J. and Jaafari, M. R. (2020) Doxil chemotherapy plus liposomal P5 immunotherapy decreased myeloid-derived suppressor cells in murine model of breast cancer. Nanomedicine: Nanotechnology, Biology, and Medicine, 24.

Navashenaq, J. G. and Zamani, P. and Nikpoor, A. R. and Tavakkol-Afshari, J. and Jaafari, M. R. (2020) Doxil chemotherapy plus liposomal P5 immunotherapy decreased myeloid-derived suppressor cells in murine model of breast cancer. Nanomedicine: Nanotechnology, Biology, and Medicine, 24.

Zamani, P. and Oskuee, R. K. and Atkin, S. L. and Navashenaq, J. G. and Sahebkar, A. (2020) MicroRNAs as important regulators of the NLRP3 inflammasome. Progress in Biophysics and Molecular Biology, 150. pp. 50-61.

Zamani, P. and Teymouri, M. and Nikpoor, A. R. and Navashenaq, J. G. and Gholizadeh, Z. and Darban, S. A. and Jaafari, M. R. (2020) Nanoliposomal vaccine containing long multi-epitope peptide E75-AE36 pulsed PADRE-induced effective immune response in mice TUBO model of breast cancer. European Journal of Cancer, 129. pp. 80-96.

Zamani, P. and Teymouri, M. and Nikpoor, A. R. and Navashenaq, J. G. and Gholizadeh, Z. and Darban, S. A. and Jaafari, M. R. (2020) Nanoliposomal vaccine containing long multi-epitope peptide E75-AE36 pulsed PADRE-induced effective immune response in mice TUBO model of breast cancer. European Journal of Cancer, 129. pp. 80-96.

Zamani, P. and Teymouri, M. and Nikpoor, A. R. and Navashenaq, J. G. and Gholizadeh, Z. and Darban, S. A. and Jaafari, M. R. (2020) Nanoliposomal vaccine containing long multi-epitope peptide E75-AE36 pulsed PADRE-induced effective immune response in mice TUBO model of breast cancer. European Journal of Cancer, 129. pp. 80-96.

Karimi, M. and Gheybi, F. and Zamani, P. and Mashreghi, M. and Golmohammadzadeh, S. and Darban, S. A. and Badiee, A. and Jaafari, M. R. (2020) Preparation and characterization of stable nanoliposomal formulations of curcumin with high loading efficacy: In vitro and in vivo anti-tumor study. International Journal of Pharmaceutics, 580.

Soleimani, A. and Farshchi, H. K. and Mirzavi, F. and Zamani, P. and Ghaderi, A. and Amini, Y. and Khorrami, S. and Mashayekhi, K. and Jaafari, M. R. (2020) The therapeutic potential of targeting CD73 and CD73-derived adenosine in melanoma. Biochimie, 176. pp. 21-30.

Abolbashari, S. and Darroudi, S. and Tayefi, M. and Khashyarmaneh, Z. and Zamani, P. and Haghighi, H. M. and Mohammadpour, A. H. and Tavalaei, S. and Ahmadnezhad, M. and Esmaily, H. and Ferns, G. A. and Meshkat, Z. and Ghayour-Mobarhan, M. (2019) Association between serum zinc and copper levels and antioxidant defense in subjects infected with human t-lymphotropic virus type 1. Journal of Blood Medicine, 10. pp. 29-35.

Nikpoor, A. R. and Jaafari, M. R. and Zamani, P. and Teymouri, M. and Gouklani, H. and Saburi, E. and Darban, S. A. and Badiee, A. and Bahramifar, A. and Fasihi-Ramandi, M. and Taheri, R. A. (2019) Cell cytotoxicity, immunostimulatory and antitumor effects of lipid content of liposomal delivery platforms in cancer immunotherapies. A comprehensive in-vivo and in-vitro study. International Journal of Pharmaceutics, 567.

Nikpoor, A. R. and Jaafari, M. R. and Zamani, P. and Teymouri, M. and Gouklani, H. and Saburi, E. and Darban, S. A. and Badiee, A. and Bahramifar, A. and Fasihi-Ramandi, M. and Taheri, R. A. (2019) Cell cytotoxicity, immunostimulatory and antitumor effects of lipid content of liposomal delivery platforms in cancer immunotherapies. A comprehensive in-vivo and in-vitro study. International Journal of Pharmaceutics, 567.

Zamani, P. and Navashenaq, J. G. and Nikpoor, A. R. and Hatamipour, M. and Oskuee, R. K. and Badiee, A. and Jaafari, M. R. (2019) MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer. Journal of Controlled Release, 303. pp. 223-236.

Zamani, P. and Navashenaq, J. G. and Nikpoor, A. R. and Hatamipour, M. and Oskuee, R. K. and Badiee, A. and Jaafari, M. R. (2019) MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer. Journal of Controlled Release, 303. pp. 223-236.

Zamani, P. and Navashenaq, J. G. and Nikpoor, A. R. and Hatamipour, M. and Oskuee, R. K. and Badiee, A. and Jaafari, M. R. (2019) MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer. Journal of Controlled Release, 303. pp. 223-236.

Hasanzadeh, L. and Darroudi, M. and Ramezanian, N. and Zamani, P. and Aghaee-Bakhtiari, S. H. and Nourmohammadi, E. and Kazemi Oskuee, R. (2019) Polyethylenimine-associated cerium oxide nanoparticles: A novel promising gene delivery vector. Life Sciences, 232.

Nik, M. E. and Momtazi-Borojeni, A. A. and Zamani, P. and Navashenaq, J. G. and Iranshahi, M. and Jaafari, M. R. and Malaekeh-Nikouei, B. (2019) Targeted-nanoliposomal combretastatin A4 (CA-4) as an efficient antivascular candidate in the metastatic cancer treatment. Journal of Cellular Physiology, 234 (9). pp. 14721-14733.

Nik, M. E. and Momtazi-Borojeni, A. A. and Zamani, P. and Navashenaq, J. G. and Iranshahi, M. and Jaafari, M. R. and Malaekeh-Nikouei, B. (2019) Targeted-nanoliposomal combretastatin A4 (CA-4) as an efficient antivascular candidate in the metastatic cancer treatment. Journal of Cellular Physiology, 234 (9). pp. 14721-14733.

Nik, M. E. and Momtazi-Borojeni, A. A. and Zamani, P. and Navashenaq, J. G. and Iranshahi, M. and Jaafari, M. R. and Malaekeh-Nikouei, B. (2019) Targeted-nanoliposomal combretastatin A4 (CA-4) as an efficient antivascular candidate in the metastatic cancer treatment. Journal of Cellular Physiology, 234 (9). pp. 14721-14733.

Oskouie, M. N. and Aghili Moghaddam, N. S. and Butler, A. E. and Zamani, P. and Sahebkar, A. (2019) Therapeutic use of curcumin-encapsulated and curcumin-primed exosomes. Journal of Cellular Physiology, 234 (6). pp. 8182-8191.

Zamani, P. and Fereydouni, N. and Butler, A. E. and Navashenaq, J. G. and Sahebkar, A. (2019) The therapeutic and diagnostic role of exosomes in cardiovascular diseases. Trends in Cardiovascular Medicine, 29 (6). pp. 313-323.

Norouzi, S. and Gorgi Valokala, M. and Mosaffa, F. and Zirak, M. R. and Zamani, P. and Behravan, J. (2018) Crosstalk in cancer resistance and metastasis. Critical Reviews in Oncology/Hematology, 132. pp. 145-153.

Askari, V. R. and Rahimi, V. B. and Zamani, P. and Fereydouni, N. and Rahmanian-Devin, P. and Sahebkar, A. H. and Rakhshandeh, H. (2018) Evaluation of the effects of Iranian propolis on the severity of post operational-induced peritoneal adhesion in rats. Biomedicine and Pharmacotherapy, 99. pp. 346-353.

Zamani, P. and Matbou Riahi, M. and Momtazi-Borojeni, A. A. and Jamialahmadi, K. (2018) Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma. Artificial Cells, Nanomedicine and Biotechnology, 46 (7). pp. 1301-1313.

Heidari-Bakavoli, A. and Hassanian, S. M. and Avan, A. and Shafiee, M. and Bahrami, A. and Tayefi, M. and Khakpouri, S. and Zamani, P. and Moohebati, M. and Ebrahimi, M. and Rahmani, F. and Esmaeily, H. and Nematy, M. and Safarian, M. and Ferns, G. A. and Azarpajouh, M. R. and Parizadeh, M. R. and Ghayour-Mobarhan, M. (2018) Hypertriglyceridemia is associated with white blood cell count and red cell distribution width: A gender stratified analysis in a population-based study. Acta Medica Iranica, 56 (10). pp. 645-652.

Zamani, P. and Momtazi-Borojeni, A. A. and Nik, M. E. and Oskuee, R. K. and Sahebkar, A. (2018) Nanoliposomes as the adjuvant delivery systems in cancer immunotherapy. Journal of Cellular Physiology, 233 (7). pp. 5189-5199.

Emamian, M. and Hasanian, S. M. and Tayefi, M. and Bijari, M. and Movahedian far, F. and Shafiee, M. and Avan, A. and Heidari-Bakavoli, A. and Moohebati, M. and Ebrahimi, M. and Darroudi, S. and Zamani, P. and Azarpazhooh, M. R. and Nematy, M. and Safarian, M. and Ferns, G. A. and Esmaeili, H. and Parizadeh, M. R. and Ghayour-Mobarhan, M. (2017) Association of hematocrit with blood pressure and hypertension. Journal of Clinical Laboratory Analysis, 31 (6).

This list was generated on Wed May 25 08:51:33 2022 EDT.